CFG
38
-2
EIX
69
3
MCO
80
2
BAC
41
-6
HRL
30
-5
RF
51
-2
SWKS
38
-2
JBHT
50
-6
MMM
52
2
VRSN
53
-2
NRG
69
12
MAS
67
-3
EMN
70
-2
FMC
40
4
PEP
47
-3
KEY
51
-3
NTRS
49
-5
IFF
56
-3
ETR
68
2
LMT
47
7
CFG
38
-2
EIX
69
3
MCO
80
2
BAC
41
-6
HRL
30
-5
RF
51
-2
SWKS
38
-2
JBHT
50
-6
MMM
52
2
VRSN
53
-2
NRG
69
12
MAS
67
-3
EMN
70
-2
FMC
40
4
PEP
47
-3
KEY
51
-3
NTRS
49
-5
IFF
56
-3
ETR
68
2
LMT
47
7
Financhill
Back

Vanguard Consumer Discretionary ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
61

VCR
Vanguard Consumer Discretionary ETF

Last Price:
336.08
Seasonality Move:
1.11%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
61
Vanguard Consumer Discretionary ETF (VCR) is a Buy

Is Vanguard Consumer Discretionary ETF a Buy, Sell or Hold?

  • The current Vanguard Consumer Discretionary ETF [VCR] share price is $336.24. The Score for VCR is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • VCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

VCR Stock Price Chart

What is Vanguard Consumer Discretionary ETF's stock price today?

  • The Vanguard Consumer Discretionary ETF share price today is $336.24
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

VCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.32 Buy
Relative Strength Index (14 RSI): 66.66 Buy
Chaikin Money Flow: 22581 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (314.43 - 327.99) Buy
Bollinger Bands (100): (303.97 - 322.15) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

VCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 329.57 Buy
20-day SMA: 322.24 Buy
50-day SMA: 316.69 Buy
200-day SMA: 308.56 Buy
8-day EMA: 329.94 Buy
20-day EMA: 323.68 Buy
50-day EMA: 318.1 Buy
200-day EMA: 306.07 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Vanguard Consumer Discretionary ETF Earnings Growth & VCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Vanguard Consumer Discretionary ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):